Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

12

Number of overlapping holdings

32.4%

% of IHE's 38 holdings also in PPH

50.0%

% of PPH's 27 holdings also in IHE

Overlap by Weight
Sector Drift (IHE minus PPH)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in IHE
Weight
in PPH
Overlap
ELI LILLY & CO 22.7% 11.9% 11.9%
JOHNSON & JOHNSON 22.8% 6.6% 6.6%
ZOETIS INC 4.6% 4.6% 4.6%
BRISTOL-MYERS SQUIBB CO 4.6% 4.5% 4.5%
PFIZER INC 4.5% 4.4% 4.4%

Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to PPH
JOHNSON & JOHNSON 16.2%
ELI LILLY & CO 10.9%
INTRA-CELLULAR THERAPIES INC 4.6%
ROYALTY PHARMA PLC CLASS A 4.3%
CORCEPT THERAPEUTICS INC 2.1%
VIATRIS, INC. 2.0%
PRESTIGE BRANDS HOLDINGS INC 1.8%
JAZZ PHARMACEUTICALS PLC 1.2%
ELANCO ANIMAL HEALTH, INC. 1.1%
AXSOME THERAPEUTICS, INC. 0.9%
IHE Underweight Relative to PPH
ABBVIE INC -6.5%
NOVARTIS AG-ADR -5.2%
ASTRAZENECA PLC-SPONS ADR -4.9%
CENCORA INC -4.9%
SANOFI-AVENTIS-ADR -4.9%
MCKESSON CORP -4.7%
NOVO-NORDISK A/S-SPONS ADR -4.7%
TAKEDA PHARMACEUTICAL CO. LTD. SPONS -4.6%
GLAXOSMITHKLINE PLC-SPON ADR -4.5%
TEVA PHARMACEUTICAL-SP ADR -4.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY